Search details
1.
Quantitative temporal viromics: an approach to investigate host-pathogen interaction.
Cell
; 157(6): 1460-1472, 2014 Jun 05.
Article
in English
| MEDLINE | ID: mdl-24906157
2.
HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation.
Proc Natl Acad Sci U S A
; 120(49): e2309077120, 2023 Dec 05.
Article
in English
| MEDLINE | ID: mdl-38011551
3.
ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways.
Proc Natl Acad Sci U S A
; 120(33): e2303155120, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-37561786
4.
Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex.
Proc Natl Acad Sci U S A
; 119(6)2022 02 08.
Article
in English
| MEDLINE | ID: mdl-35105802
5.
The cytokine receptor DR3 identifies and promotes the activation of thymic NKT17 cells.
Cell Mol Life Sci
; 80(3): 76, 2023 Feb 27.
Article
in English
| MEDLINE | ID: mdl-36847849
6.
Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses.
Proc Natl Acad Sci U S A
; 115(19): 4998-5003, 2018 05 08.
Article
in English
| MEDLINE | ID: mdl-29691324
7.
Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8+ T-cell evasion.
J Gen Virol
; 101(8): 863-872, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32510303
8.
Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels.
BMC Musculoskelet Disord
; 20(1): 326, 2019 Jul 12.
Article
in English
| MEDLINE | ID: mdl-31299941
9.
Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.
Am J Pathol
; 186(11): 2813-2823, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27664471
10.
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Immunity
; 29(1): 79-89, 2008 Jul 18.
Article
in English
| MEDLINE | ID: mdl-18571443
11.
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation.
PLoS Pathog
; 10(5): e1004058, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24787765
12.
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.
Gut
; 63(3): 515-24, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-23665989
13.
Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.
J Immunol
; 188(6): 2794-804, 2012 Mar 15.
Article
in English
| MEDLINE | ID: mdl-22345649
14.
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.
Eur J Immunol
; 42(9): 2383-94, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22653709
15.
DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor.
Am J Pathol
; 180(4): 1454-64, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22330679
16.
The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⺠and CD8⺠T-cell immunity.
FASEB J
; 26(8): 3575-86, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22593543
17.
IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection.
J Immunol
; 187(6): 2944-52, 2011 Sep 15.
Article
in English
| MEDLINE | ID: mdl-21849677
18.
Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.
FASEB J
; 25(1): 409-19, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20826539
19.
The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.
J Immunol
; 184(10): 5827-34, 2010 May 15.
Article
in English
| MEDLINE | ID: mdl-20410491
20.
An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants.
Hum Gene Ther
; 33(17-18): 990-1001, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35196879